Share your voice — Be featured in Notable Men

The Notable Men Podcast

Trust Before Technology: Leading Healthcare Innovation with Integrity

Hosted by Laura Ezzell

The Notable Men Podcast
Featured Guest
William Soliman

Now Playing

Trust Before Technology: Leading Healthcare Innovation with Integrity

In this episode of the Notable Men Podcast, Laura Ezzell sits down with entrepreneur, healthcare executive, investor, and pharmaceutical industry leader William Soliman, PhD, BCMAS.

William is the Founder and CEO of the Accreditation Council for Medical Affairs (ACMA), the organization responsible for setting professional standards across the pharmaceutical industry through education, certification, and accreditation. He is also the Founder and Chief Investment Officer of White Manna Capital Partners, a healthcare-focused hedge fund investing in biotechnology, obesity treatment, women's health, and emerging medical innovation.

Throughout his career, William has worked at the intersection of science, business, ethics, and healthcare policy. From helping establish professional standards for medical affairs to investing in the next generation of healthcare breakthroughs, his work centers on one guiding principle: innovation should always serve patients first.

In this conversation, William reflects on the ethical challenges that shaped his career, including his early experience during the Vioxx controversy, and explains why transparency, accountability, and trust remain essential as artificial intelligence rapidly transforms medicine.

He also explores how AI is accelerating drug discovery, why obesity and women's health represent major frontiers in healthcare innovation, and what separates companies that create lasting value from those driven by hype.

In this conversation, William shares:

  • Why ethical leadership matters more than ever in healthcare
  • Lessons learned from the Vioxx controversy and standing by your values
  • How AI is transforming pharmaceutical research and drug development
  • Why human oversight will always remain essential in medicine
  • The importance of transparency and rebuilding trust in healthcare
  • What investors should look for beyond industry excitement
  • Why obesity treatment is only in its earliest stages
  • How women's health is becoming one of healthcare's biggest opportunities
  • The role certification and education play in improving patient outcomes
  • Why specialized expertise and personal branding matter for future leaders
  • The qualities every healthcare startup needs before seeking investment
  • How innovation can move faster without compromising integrity

Healthcare is changing faster than ever before, but William argues that technological advancement alone isn't enough. Lasting innovation requires ethical leadership, trusted systems, and a commitment to improving patient care above all else.

Whether you're interested in healthcare, entrepreneurship, investing, artificial intelligence, or leadership, this conversation offers valuable insight into the decisions shaping the future of medicine.

Connect with William Soliman

LinkedIn: https://www.linkedin.com/in/drwilliamsoliman/

Instagram: https://www.instagram.com/will_soliman/

TikTok: https://www.tiktok.com/@willsoliman

YouTube: https://www.youtube.com/@willsoliman

About The Guest
William Soliman

William Soliman

William Soliman, PhD, BCMAS, is the Founder/CEO of the Accreditation Council for Medical Affairs (ACMA), the company that accredits, certifies and trains the pharma field force. He's also the Founder/CIO of White Manna Capital Partners, a long/short public equities healthcare, biotech, and pharma hedge fund. Dr. Soliman is a former senior pharmaceutical industry executive with deep experience in medical affairs, pharmaceutical industry commercialization, reimbursement and innovative capital allocation strategies in healthcare. He is widely recognized for advancing the industry standard for the Medical Affairs and MSL profession through the establishment of the Board Certified Medical Affairs Specialist (BCMAS) program.